-+ 0.00%
-+ 0.00%
-+ 0.00%

NexgenRx Swings to Q3 Net Loss of $63,993

PUBT·11/19/2026 23:20:32
Listen to the news
NexgenRx Swings to Q3 Net Loss of $63,993
  • NexgenRx swung to a third-quarter 2026 net loss of $63,993 due to a $907,728 income tax expense.
  • Income before income taxes climbed 49% to $843,735, while revenue rose 8% to $4.9 million from a year earlier.
  • For the nine months ended September 30, 2026, net income increased 47% year over year to $2.2 million.
  • The company incorporated several AI-based initiatives into its operations, targeting workflow efficiency, stronger analytics and better-informed decisions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NexgenRX Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202611191820ACCESSWRNAPR_____1254592) on November 19, 2026, and is solely responsible for the information contained therein.